MedTrace Logo

A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD

NCT01749215 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 151

Last updated 2021-06-21

Study results available
· View outcomes & findings →

Summary

The goal of this project is to improve the treatment of veterans with co-occurring alcohol dependence and posttraumatic stress disorder (PTSD). The PI and co-investigators will conduct a controlled clinical trial of topiramate for the treatment of these co-occurring disorders.

Conditions

  • Alcohol Dependence
  • Posttraumatic Stress Disorder (PTSD)

Interventions

DRUG

Topiramate

Experimental study drug

DRUG

placebo

Placebo comparator

BEHAVIORAL

Medical Management

Brief alcohol counseling

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • San Francisco Veterans Affairs Medical Center

    collaborator FED

  • Northern California Institute of Research and Education

    collaborator OTHER

  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • Steven L. Batki, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2019-07-31
Completion
2019-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01749215 on ClinicalTrials.gov